Results 171 to 180 of about 22,145 (200)

Targeting NKG2D/NKG2D ligand axis for cancer immunotherapy

2023
openaire   +1 more source

Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness

Journal of Hepatology, 2021
Séverine Celton-Morizur, Angélique Gougelet, Sabine Colnot   +2 more
exaly  

ANTIBODIES BINDING TO NKG2D

2021
DENGL STEFAN, GEORGES GUY, HOSSE RALF, WALDHAUER INJA, KLEIN CHRISTIAN, UMANA PABLO   +5 more
openaire   +3 more sources

Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy

Cellular and Molecular Immunology, 2018
Cynthia Perez, José A Guevara-Patino, Kushal Prajapati   +2 more
exaly  

NKG2D

2011
openaire   +1 more source

The role of the NKG2D receptor for tumor immunity

Seminars in Cancer Biology, 2006
Jerome David Coudert, Werner Held
exaly  

TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients.

Neuro-Oncology, 2010
Seunggu Jude Han, Lewis L Lanier, Andrew T Parsa   +2 more
exaly  

Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy

International Journal of Molecular Sciences, 2018
Yanzhang Wei, Hui Ding
exaly  

NKG2D decoys

2017
STRONG ROLAND K, PRLIC MARTIN, GEWE MESFIN, SPIES THOMAS, SPIES VERONIKA, RUPERT PETER   +5 more
openaire   +3 more sources

NKG2D

2008
openaire   +1 more source